Correlation between maternal weight and phenylephrine dose during cesarean section under combined spinal and epidural anesthesia

Correlation between maternal weight and phenylephrine dosage during cesarean section under combined spinal and epidural anesthesia

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000029705

Enrollment

Unknown

Registered

2020-02-09

Start date

2020-08-26

Completion date

Unknown

Last updated

2021-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension during cesarean section

Interventions

overweight group:BMI>30

Standard group:BMI=30

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. ASA II; 2. Single pregnancy; 3. Gestational week >= 37 weeks, women who planned to undergo elective cesarean section under combined spinal and epidural anesthesia.

Exclusion criteria

Exclusion criteria: 1. Allergic to norepinephrine; 2. Early or active labor, ruptured membranes; 3. Preexisting or gestational diabetes; 4. Intrauterine growth restriction; 5. Placenta previa, and any contraindication to spinal or epidural anesthesia such as local infection or bleeding disorder.

Design outcomes

Primary

Measure	Time frame
phenylephrine dose;low blood presure;	—

Secondary

Measure	Time frame
heart beats;	—

Countries

China

Contacts

Public ContactHuang Shaoqiang

Obstetrics and Gynecology Hospital affiliated to Fudan University

drhuangsq@163.com+86 13671667155

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026